Get access

Different inactivating mutations in the LU genes of three individuals with the Lutheran-null phenotype

Authors

  • Vanja Karamatic Crew,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Gary Mallinson,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Carole Green,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Joyce Poole,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Makoto Uchikawa,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Yoshihiko Tani,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Christof Geisen,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Johannes Oldenburg,

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author
  • Geoff Daniels

    1. From the Bristol Institute for Transfusion Sciences and International Blood Group Reference Laboratory, Bristol, UK; the Japanese Red Cross, Tokyo Blood Center, Tokyo, Japan; the Japanese Red Cross, Osaka Blood Center, Osaka, Japan; the Institute of Transfusion Medicine and Immunohaematology, German Red Cross, Johann Wolfgang Goether University, Frankfurt, Germany; and the Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
    Search for more papers by this author

  • VKC is funded by a grant from DiaMed AG.

Geoff Daniels, Bristol Institute for Transfusion Sciences, Southmead Road, Bristol BS10 5ND, UK; e-mail: geoff.daniels@nbs.nhs.uk.

Abstract

BACKGROUND: The null phenotype of the Lutheran blood group system, Lunull or Lu(a–b–), is characterized by the lack of all Lutheran system antigens. It can arise from three genetic backgrounds: recessive, dominant, or X-linked. Lunull of the recessive type appears to result from homozygosity for an inactive LU gene.

STUDY DESIGN AND METHODS: Three unrelated recessive Lunull individuals were assessed by standard serologic tests. All exons of the LU gene were directly sequenced from amplified genomic DNA. The validity of the observed mutations within the LU gene was confirmed by the use of either restriction enzymes or allele-specific primers.

RESULTS: All three individuals had the serologic characteristics of recessive Lunull. One individual was doubly heterozygous for a nonsense mutation 691C>T in exon 6 (Arg231STOP) and a deletion of LU exons 3 and 4. The other two samples showed homozygous nonsense mutations: one had 711C>A in exon 6 (Cys237STOP) and the other 361C>T in exon 3 (Arg121STOP).

CONCLUSIONS: The results revealed four unique genetic backgrounds from three examples of the rare recessive Lunull phenotype, each encoding Lutheran glycoproteins with a disrupted structure.

Ancillary